41 results
6-K
EX-99.1
SPRC
SciSparc Ltd
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
children. The trial’s primary efficacy endpoints include three rigorous assessments: the Aberrant Behavior Checklist-Community (ABC-C) parent questionnaire
6-K
EX-99.3
SPRC
SciSparc Ltd
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
patients that are willing to work with the scientific community by participating in clinical trials. The enrollment of our first patient means that we … efficacy metrics: the Aberrant Behavior Checklist-Community (ABC-C) parent questionnaire; the Clinical Global Impressions-Improvement (CGI-I
6-K
EX-99.1
SPRC
SciSparc Ltd
29 Feb 24
Report of Foreign Private Issuer
9:07am
include three rigorous assessments: the Aberrant Behavior Checklist-Community (ABC-C) parent questionnaire; the Clinical Global Impressions
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
community.
Even with the requisite approvals from the FDA and comparable foreign regulatory authorities, the commercial success of our product … candidates will depend in part on the medical community, patients and third-party payors accepting our product candidates as medically useful, cost
6-K
EX-99.1
6zsrc1f0
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
F-3/A
0j99q1fvpoc7f1eev6am
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
wp9f5t2d8yfbh0ca7
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
33m43m01 a7
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
EX-99.2
9a8tt
29 Sep 23
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
7:46am
6-K
EX-99.1
d5z9rh 4u
17 Jul 23
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
8:00am
424B5
ygsujy 53o
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.3
dyvawun6o2co138dha4
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
cfp04kwcbtslm2wpx
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
F-3
kgtsnt7 0tdgr1ynohqa
7 Jul 22
Shelf registration (foreign)
4:22pm
6-K
EX-99.1
52m3lb5x9aq
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
67f84hsyikhbti11zf6w
22 Feb 22
Report of Foreign Private Issuer
9:05am
POS AM
ik30nt 40
8 Oct 21
Prospectus update (post-effective amendment)
12:00am